M&A Deal Summary

FairJourney Biologics Acquires Charles River - South San Francisco Site

On March 10, 2025, FairJourney Biologics acquired life science company Charles River - South San Francisco Site from Charles River Laboratories International

Acquisition Highlights
  • This is FairJourney Biologics’ 1st transaction in the Life Science sector.
  • This is FairJourney Biologics’ 1st transaction in the United States.
  • This is FairJourney Biologics’ 1st transaction in California.

M&A Deal Summary

Date 2025-03-10
Target Charles River - South San Francisco Site
Sector Life Science
Buyer(s) FairJourney Biologics
Sellers(s) Charles River Laboratories International
Deal Type Divestiture

Target

Charles River - South San Francisco Site

San Francisco, California, United States
Charles River's South San Francisco Site provides customers in this region with a localized source of expertise and technical support, helping them to accelerate their antibody discovery and engineering pipelines. Charles River's South San Francisco Site is based in San Francisco, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

FairJourney Biologics

Porto, Portugal

Category Company
Founded 2012
Sector Life Science
DESCRIPTION

FairJourney Biologics is a biologics CRO, providing integrated services across antibody discovery, engineering, and production to global biopharma. The company operates a flexible, customer-oriented ‘one-stop-shop’ approach to biologics development focused on quality, reliability, and partnership. FairJourney Biologics was founded in 2012 and is based in Porto, Portugal.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1

Seller(S) 1

SELLER

Charles River Laboratories International

Wilmington, Massachusetts, United States

Category Company
Founded 1947
Sector Life Science
Employees18,700
Revenue 4.1B USD (2024)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Divestiture M&A Deals 3 of 3
State: California M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-30 SAMDI Tech

Chicago, Illinois, United States

SAMDI Tech is a provider of high-quality, label-free high-throughput screening (HTS) solutions for drug discovery research. SAMDI Tech offers a proprietary mass spectrometry (MS) technology for high-throughput analysis of biochemical activities and affinity selection MS (SAMDI ASMS) for identifying binding interactions. SAMDI Tech was founded in 2011 and is based in Chicago, Illinois.

Buy $50M